Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
6.94
-0.30 (-4.14%)
At close: Jan 30, 2026, 4:00 PM EST
6.86
-0.08 (-1.22%)
After-hours: Jan 30, 2026, 7:52 PM EST
Alpha Tau Medical Employees
Alpha Tau Medical had 125 employees as of December 31, 2024. The number of employees increased by 4 or 3.31% compared to the previous year.
Employees
125
Change (1Y)
4
Growth (1Y)
3.31%
Revenue / Employee
n/a
Profits / Employee
-$319,736
Market Cap
591.73M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 125 | 4 | 3.31% |
| Dec 31, 2023 | 121 | 27 | 28.72% |
| Dec 31, 2022 | 94 | 11 | 13.25% |
| Dec 31, 2021 | 83 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Replimune Group | 479 |
| MeiraGTx Holdings | 409 |
| REGENXBIO | 353 |
| ProKidney | 204 |
| Rigel Pharmaceuticals | 164 |
| Gossamer Bio | 145 |
| CorMedix | 65 |
| Altimmune | 59 |
DRTS News
- 3 days ago - Alpha Tau Issues Letter to Shareholders: Five Concurrent Trials in the U.S. with Multiple Significant Value-Driving Milestones Ahead - GlobeNewsWire
- 9 days ago - Alpha Tau Medical: Pancreatic, GBM, And Other Updates; Set Up For A Strong, Catalyst-Rich 2026 - Seeking Alpha
- 26 days ago - Alpha Tau Reports New Positive Results in Two Upcoming Presentations at ASCO GI 2026 Symposium Showcasing Immune-Preservation and High Disease Control in Montreal Pancreatic Cancer Alpha DaRT® Study - GlobeNewsWire
- 27 days ago - Alpha Tau Submits First Pre-Market Approval Module to the FDA for Alpha DaRT® for the Treatment of Recurrent Cutaneous Squamous Cell Carcinoma (cSCC) - GlobeNewsWire
- 7 weeks ago - Alpha Tau Successfully Treats First Patient in its U.S. Trial for Patients with Recurrent Glioblastoma at the James Cancer Hospital at The Ohio State University - GlobeNewsWire
- 2 months ago - Alpha Tau Announces Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - Alpha Tau to Participate at Jefferies Global Healthcare Conference in London - GlobeNewsWire
- 3 months ago - Alpha Tau Announces Receipt of Radioactive Material License for its New Hampshire Manufacturing Facility, Advancing Towards Commercial Readiness - GlobeNewsWire